Man Group PLC Karyopharm Therapeutics Inc. Transaction History

Man Group PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.84 - $3.92 $126,664 - $174,832	44,600 New	44,600 $173,000
Q2 2022 Aug 15, 2022	BUY	$4.15 - $8.37 $14,520 - $29,286	3,499 Added 22.92%	18,765 $85,000
Q1 2022 May 16, 2022	BUY	$5.91 - $14.38 $90,222 - $219,525	15,266 New	15,266 $113,000
Q2 2021 Aug 16, 2021	SELL	$8.11 - $11.11 $94,449 - $129,387	-11,646 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$9.85 - $17.69 $587,325 - $1.05 Million	-59,627 Reduced 83.66%	11,646 $122,000
Q4 2020 Feb 16, 2021	BUY	$14.15 - $17.19 $9,041 - $10,984	639 Added 0.9%	71,273 $1.1 Million
Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $998,764 - $1.39 Million	70,634 New	70,634 $1.03 Million
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $284,724 - $548,856	-19,800 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$9.23 - $19.67 $11,076 - $23,604	-1,200 Reduced 5.71%	19,800 $380,000
Q3 2019 Nov 14, 2019	BUY	$5.66 - $11.85 $118,860 - $248,850	21,000 New	21,000 $202,000
Q1 2019 May 15, 2019	SELL	$4.12 - $10.25 $75,808 - $188,600	-18,400 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.2 - $16.95 $150,880 - $311,880	18,400 New	18,400 $172,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.